These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30645984)

  • 1. Nano-lipospheres as acoustically active ultrasound contrast agents: evolving tumor imaging and therapy technique.
    Andrews LE; Chan MH; Liu RS
    Nanotechnology; 2019 May; 30(18):182001. PubMed ID: 30645984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coating microbubbles with nanoparticles for medical imaging and drug delivery.
    Tay LM; Xu C
    Nanomedicine (Lond); 2017 Jan; 12(2):91-94. PubMed ID: 27876447
    [No Abstract]   [Full Text] [Related]  

  • 3. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
    Rapoport N; Gao Z; Kennedy A
    J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer-Based Materials in Cancer Treatment: From Therapeutic Carrier and Ultrasound Contrast Agent to Theranostic Applications.
    Methachan B; Thanapprapasr K
    Ultrasound Med Biol; 2017 Jan; 43(1):69-82. PubMed ID: 27751594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
    Hou L; Shan X; Hao L; Feng Q; Zhang Z
    Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of Nucleolin-Targeted Lipid Nanobubbles and Contrast-Enhanced Ultrasound Molecular Imaging in Triple-Negative Breast Cancer.
    Fang K; Wang L; Huang H; Lan M; Shen D; Dong S; Guo Y
    Pharm Res; 2020 Jul; 37(7):145. PubMed ID: 32666304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics.
    Min HS; You DG; Son S; Jeon S; Park JH; Lee S; Kwon IC; Kim K
    Theranostics; 2015; 5(12):1402-18. PubMed ID: 26681985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charge-reversal-functionalized PLGA nanobubbles as theranostic agents for ultrasonic-imaging-guided combination therapy.
    Yang H; Shen X; Yan J; Xie X; Chen Z; Li T; Li S; Qin X; Wu C; Liu Y
    Biomater Sci; 2018 Aug; 6(9):2426-2439. PubMed ID: 30040100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal micro, nano, and size conversion ultrasound agents for imaging and therapy.
    Huynh E; Rajora MA; Zheng G
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):796-813. PubMed ID: 27006001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Theranostic Applications and Prospects of Nanobubbles.
    Shah R; Phatak N; Choudhary A; Gadewar S; Ajazuddin ; Bhattacharya S
    Curr Pharm Biotechnol; 2024; 25(9):1167-1181. PubMed ID: 37861011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomaterials as Ultrasound Theragnostic Tools for Heart Disease Treatment/Diagnosis.
    Alphandéry E
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical gas-generating nanoparticles for tumor-targeted ultrasound imaging and ultrasound-triggered drug delivery.
    Min HS; Son S; You DG; Lee TW; Lee J; Lee S; Yhee JY; Lee J; Han MH; Park JH; Kim SH; Choi K; Park K; Kim K; Kwon IC
    Biomaterials; 2016 Nov; 108():57-70. PubMed ID: 27619240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanobubbles for enhanced ultrasound imaging of tumors.
    Yin T; Wang P; Zheng R; Zheng B; Cheng D; Zhang X; Shuai X
    Int J Nanomedicine; 2012; 7():895-904. PubMed ID: 22393289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro characterization of chitosan nanobubbles as theranostic agents.
    Cavalli R; Argenziano M; Vigna E; Giustetto P; Torres E; Aime S; Terreno E
    Colloids Surf B Biointerfaces; 2015 May; 129():39-46. PubMed ID: 25819364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound nanotheranostics in fighting cancer: Advances and prospects.
    Zhou LQ; Li P; Cui XW; Dietrich CF
    Cancer Lett; 2020 Feb; 470():204-219. PubMed ID: 31790760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic nanobubbles with potential for targeted drug delivery and trimodal imaging in breast cancer: an in vitro study.
    Song W; Luo Y; Zhao Y; Liu X; Zhao J; Luo J; Zhang Q; Ran H; Wang Z; Guo D
    Nanomedicine (Lond); 2017 May; 12(9):991-1009. PubMed ID: 28327075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balancing stealth and echogenic properties in an ultrasound contrast agent with drug delivery potential.
    Jablonowski LJ; Alfego D; Andorko JI; Eisenbrey JR; Teraphongphom N; Wheatley MA
    Biomaterials; 2016 Oct; 103():197-206. PubMed ID: 27388945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in nanobubbles for cancer theranostics: Delivery, imaging and therapy.
    Na L; Fan F
    Biochem Pharmacol; 2024 Aug; 226():116341. PubMed ID: 38848778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatible PEGylated bismuth nanocrystals: "All-in-one" theranostic agent with triple-modal imaging and efficient in vivo photothermal ablation of tumors.
    Li Z; Liu J; Hu Y; Li Z; Fan X; Sun Y; Besenbacher F; Chen C; Yu M
    Biomaterials; 2017 Oct; 141():284-295. PubMed ID: 28709019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.